Selección de DES para Diabéticos: Análisis de evidencias

albertal_mariano_diabeticos
Mariano Albertal
2012-10-04

More articles by this author

Intervenciones coronarias: optimizando la farmacología

Conrad Simpfendorfer.2012-10-04

¿Qué tanto nos adherimos a las guidelines AHA?

Dario Echeverri 2012-10-04

Hybrid coronary revascularization: is this in your future?

César Mendoza2012-10-04

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...